UCB S.A.: all 580 studies

Page 5 of 6. Open to participants first (26), then studies with results posted, then the rest; newest registration first within each.

• A Study to Test the Safety, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous Doses of UCB0107 in Healthy Male SubjectsCompletedNCT03464227Phase 1
• A Study to Investigate the Bioequivalence of Lacosamide 200mg Administered as Intravenous Solution and Oral Tablet in Healthy Chinese Male SubjectsCompletedNCT03204474Phase 1
• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB0942 in Healthy Japanese and Caucasian SubjectsCompletedNCT03168984Phase 1
• A Study to Investigate the Bioequivalence of Lacosamide Tablet (200mg) and Syrup (10mg/ml) in Healthy Chinese Male SubjectsCompletedNCT03086382Phase 1
• A Study to Demonstrate the Bioequivalence of Lacosamide Tablets and Dry Syrup in Healthy Male Japanese SubjectsCompletedNCT02972125Phase 1
• A First-In-Human Study With a Single Ascending Dose of UCB7858 in Healthy VolunteersCompletedNCT02879877Phase 1
• A First-In-Human Study With a Single Dose UCB4019 in Healthy VolunteersCompletedNCT02873767Phase 1
• A Phase 2 Study of Radiprodil in Subjects With Drug-resistant Infantile Spasms (IS)TerminatedNCT02829827Phase 2
• Open-label, Bioequivalence Study of Certolizumab Pegol 200 mg Solution Injected Either by a Prefilled Syringe (Reference) or by an E-Device (Test) in Healthy SubjectsCompletedNCT02806219Phase 1
• UCB Cimzia Pregnancy Follow-up StudyTerminatedNCT02775656
• Study to Evaluate Properties of Radiprodil Given in Oral Solution to Healthy VolunteersCompletedNCT02647697Phase 1
• UCB Proof of Concept Study in Patients With Primary Sjögren's SyndromeTerminatedNCT02610543Phase 2
• A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy VolunteersCompletedNCT02602860Phase 1
• A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of UCB4940 in Patients With PsoriasisCompletedNCT02529956Phase 1
• Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid ArthritisCompletedNCT02430909Phase 2
• Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable SchizophreniaCompletedNCT02411526Phase 1
• A Study of Certolizumab Pegol to Evaluate Pharmacokinetics and Safety in Adult Healthy Chinese SubjectsCompletedNCT02365948Phase 1
• A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily LifeCompletedNCT02354105
• Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the BloodCompletedNCT02306629Phase 1
• Study to Assess Safety, Tolerability, Pharmacokinetic & Pharmacodynamic Effect of UCB5857 in Healthy & Psoriatic SubjectCompletedNCT02303509Phase 1
• Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Extended-Release (HC-ER) in Subjects With Renal ImpairmentCompletedNCT02244762Phase 1
• Pharmacokinetics and Metabolism of Hydrocodone Bitartrate Controlled-Release (HC-CR) in Subjects With Hepatic ImpairmentCompletedNCT02242734Phase 1
• Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's DiseaseCompletedNCT02227355
• A Safety, Tolerability and Pharmacokinetic Dose Escalation Study of HC-ER in Patients With Osteoarthritis PainCompletedNCT02222740Phase 2
• A First-In-Human Study With a Single Dose UCB7665 in Healthy VolunteersCompletedNCT02220153Phase 1
• Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profiles of UCB5857 in Healthy SubjectsCompletedNCT02207595Phase 1
• A Multicenter Active Comparator Study of HC-ER in Adults Following Bunionectomy SurgeryCompletedNCT02197156Phase 2
• Multiple Dose Study of UCB4940 in Subjects With Psoriatic ArthritisCompletedNCT02141763Phase 1
• A Study to Determine the Influence of Co-ingestion of Alcohol on Hydrocodone Bitartrate Extended Release (HC-ER)CompletedNCT02126917Phase 1
• To Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release CapsulesCompletedNCT02117141Phase 1
• Pharmacokinetic Properties of Isosorbide-5-mononitrate Under Fasting and Fed Condition in Healthy Male SubjectsCompletedNCT02101710Phase 1
• Single-site, Open-label, Randomized, Cross-over Study in Healthy Chinese Subjects to Evaluate the Bioequivalence of Single-dose Rotigotine Transdermal Patch Comparing 2 Different FormulationsCompletedNCT02070796Phase 1
• Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese SubjectsCompletedNCT01986608Phase 1
• Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean SubjectsCompletedNCT01964573Phase 1
• A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery StrokeTerminatedNCT01883011Phase 4
• Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Repeated Dose Transdermal Rotigotine in Japanese and Caucasian SubjectsCompletedNCT01854216Phase 1
• Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy SubjectsCompletedNCT01796938Phase 1
• Comparison of Brivaracetam Oral Tablet (10 mg, 50 mg, 75 mg and 100 mg) and Brivaracetam Injection (100 mg) in Healthy VolunteersCompletedNCT01796899Phase 1
• Safety Study of CDP7657 in Patients With Systemic Lupus ErythematosusCompletedNCT01764594Phase 1
• Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) InhibitorsCompletedNCT01764321
• Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female SubjectsCompletedNCT01761526Phase 1
• Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy MalesCompletedNCT01725009Phase 1
• A Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male SubjectsCompletedNCT01710670Phase 1
• Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine Transdermal Patch in Healthy Chinese SubjectsCompletedNCT01675024Phase 1
• A Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's DiseaseWithdrawnNCT01635621Phase 2
• An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in ChineseCompletedNCT01618903Phase 1
• A Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of Bid Dosing in Chinese Healthy VolunteersCompletedNCT01618877Phase 1
• A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With SchizophreniaCompletedNCT01592110Phase 1
• Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)TerminatedNCT01577264
• Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese SubjectsCompletedNCT01565018Phase 1
• Open Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) SubjectsCompletedNCT01534403Phase 2
• A Multicenter, Open-label Study to Determine the Effects of Lacosamide on Sleep in Healthy SubjectsCompletedNCT01530386Phase 1
• Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy SubjectsCompletedNCT01530022Phase 1
• Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab PegolCompletedNCT01526434
• Effect of Lacosamide 200 mg Twice a Day (Bid) on Single Dose Warfarin 25 mg in Healthy MalesCompletedNCT01526083Phase 1
• Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With RotigotineCompletedNCT01504529
• Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) TherapyCompletedNCT01463059Phase 2
• To Evaluate the Pharmacokinetics and Safety/Tolerability of Lacosamide in 3 Dosages in Healthy Male Korean SubjectsCompletedNCT01450111Phase 1
• Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)CompletedNCT01449071Phase 1/2
• Bioequivalence Study of Levetiracetam Tablet and Intravenous Infusion in Healthy Japanese SubjectsCompletedNCT01394224Phase 1
• Three-way-cross-over Study to Evaluate Safety and Pharmacokinetics of Lacosamide in Healthy Japanese and Chinese MalesCompletedNCT01375387Phase 1
• Study to Compare Adhesiveness of Two Different Rotigotine Patch FormulationsCompletedNCT01338896Phase 1
• The First Clinical Study to Test Safety, Blood Levels and Other Effects of CDP6038 in Healthy MalesCompletedNCT01276119Phase 1
• Pharmacokinetic (PK)/Pharmacodynamic (PD), Study of Single-dose Subcutaneous CDP6038 in Healthy Japanese Male SubjectsCompletedNCT01262794Phase 1
• Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) TherapyCompletedNCT01242488Phase 2
• Named Patient Program With Rotigotine Transdermal SystemCompletedNCT01095484
• National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs)CompletedNCT01095393
• Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)CompletedNCT01093911Phase 1
• Evaluation of the Effects of Certolizumab Pegol on Semen Quality in Healthy Male VolunteersCompletedNCT01091220Phase 1
• To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using MethotrexateCompletedNCT01009242Phase 1/2
• Human Pharmacology Study (Keppra Dry Syrup Bioequivalence Study)CompletedNCT00985348Phase 1
• A Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic NeuropathyCompletedNCT00861445Phase 2
• A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN).CompletedNCT00861068Phase 2
• An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic NeuropathyCompletedNCT00861042Phase 2
• Bio-availability Comparison of Three Formulations of Certolizumab Pegol in Healthy VolunteersCompletedNCT00813774Phase 1
• A Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927CompletedNCT00800215Phase 2
• Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: BrivaracetamCompletedNCT00736931Phase 1
• CDP323 Biomarker StudyCompletedNCT00726648Phase 1/2
• Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active DiseaseCompletedNCT00660881Phase 2
• Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in EpilepsyCompletedNCT00643500Phase 4
• Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic RhinitisCompletedNCT00639587Phase 3
• A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in EpilepsyCompletedNCT00631150Phase 4
• S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in EpilepsyCompletedNCT00630968Phase 4
• Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial EpilepsyCompletedNCT00630630Phase 4
• Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial EpilepsyCompletedNCT00630357Phase 4
• Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active DiseaseCompletedNCT00624351Phase 2
• A Study on the Intraject Instructions for UseCompletedNCT00619554
• Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset SeizuresCompletedNCT00615615Phase 3
• Efficacy and Safety of Levetiracetam in Routine Clinical Practice in Czech and Slovak Republics, Hungary, and Romania.CompletedNCT00614549
• A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject SystemCompletedNCT00614029Phase 1
• Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type)CompletedNCT00612859Phase 2
• Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset SeizuresCompletedNCT00610454Phase 2
• Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind MethodCompletedNCT00600509Phase 2
• Evaluation of Safety of Levocetirizine in Routine Clinical Practice-non- Interventional StudyCompletedNCT00598780
• Efficacy and Safety of Piracetam Taken for 12 Months in Subjects Suffering From Mild Cognitive Impairment (MCI)CompletedNCT00567060Not applicable
• Efficacy and Safety of CDP870 Versus Placebo in the Treatment of the Signs and Symptoms of Rheumatoid ArthritisCompletedNCT00548834Phase 3
• A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence SeizuresCompletedNCT00545012Phase 2
• Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive SubjectsCompletedNCT00544388Phase 3
• Efficacy and Safety of CDP870 and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid ArthritisCompletedNCT00544154Phase 3
• Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years OldCompletedNCT00544050Phase 2

← UCB S.A. overview and focus areas